Last updated: April 19, 2024
Sponsor: Belal Alshaikh
Overall Status: Completed
Phase
N/A
Condition
Diet And Nutrition
Treatment
Early exclusive enteral nutrition
Clinical Study ID
NCT03708068
REB18-0772
Ages < 48 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Preterm infants born at 30 0/7 - 33 6/7 weeks gestation
- Birth weight greater than 1000 g
- Consent to use donor human milk
- Postnatal age is less than 48 hours from birth
- Infant is ready to start on feeding (as per clinical team) or feeding volume, whenalready started, is ≤12 ml/kg per day (total) and/or the infant received ≤2 feedsbased on current feeding policy or physician descrition (total volume of the receivedfeeds is ≤20 ml/kg per day).
Exclusion
Exclusion Criteria:
- Cord PH < 7.00 or Cord base access (BE) < -16
- Apgar score < 7 at 5 minute
- Lactate level ≥3 (if done for clinical indication)
- Need for positive pressure ventilation (PPV) for >1 minute.
- Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours)
- Small for gestational age <3 percentile on Fenton chart and/or fetal absent orreversed umbilical arterial end-diastolic blood flow.
- Major congenital malformation
- Symptomatic or severe hypoglycemia (blood glucose <1.8 mmol/L)
- Infants with moderate to severe respiratory distress.
Study Design
Total Participants: 69
Treatment Group(s): 1
Primary Treatment: Early exclusive enteral nutrition
Phase:
Study Start date:
April 16, 2019
Estimated Completion Date:
January 30, 2024
Study Description
Connect with a study center
Foothills Medical Centre
Calgary, Alberta T2N2T9
CanadaSite Not Available
Peter Lougheed Hospital
Calgary, Alberta T1Y6J4
CanadaSite Not Available
South Health Campus
Calgary, Alberta T3M1P9
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.